PWM
ABBV icon

Pacific Wealth Management’s AbbVie ABBV Stock Holding History

Pacific Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.63M Sell
38,268
-184
-0.5% -$39.6K 4.27% 5
2026
Q1 		$8.36M Sell
38,452
-275
-0.7% -$61K 4.5% 5
2025
Q4 		$8.85M Sell
38,727
-785
-2% -$179K 4.11% 6
2025
Q3 		$9.15M Hold
39,512
– – 4.61% 5
2025
Q2 		$7.33M Sell
39,512
-137
-0.3% -$25.5K 3.62% 8
2025
Q1 		$8.31M Sell
39,649
-237
-0.6% -$46.1K 4.57% 6
2024
Q4 		$7.09M Sell
39,886
-370
-0.9% -$68K 3.75% 7
2024
Q3 		$7.95M Sell
40,256
-142
-0.4% -$26.5K 3.7% 7
2024
Q2 		$6.93M Buy
40,398
+727
+2% +$120K 3.53% 6
2024
Q1 		$6.15M Hold
39,671
– – 3.51% 7
2023
Q4 		$6.15M Buy
39,671
+99
+0.3% +$14.4K 3.51% 7
2023
Q3 		$5.9M Buy
39,572
+378
+1% +$55.5K 3.88% 6
2023
Q2 		$5.28M Sell
39,194
-2,564
-6% -$376K 3.43% 8
2023
Q1 		$6.66M Buy
41,758
+408
+1% +$62.4K 4.27% 6
2022
Q4 		$6.68M Buy
41,350
+544
+1% +$83.4K 4.91% 7
2022
Q3 		$5.48M Buy
+40,806
New +$5.86M 4.86% 7

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pacific Wealth Management's ABBV Position: Q2 2026 in Review

Pacific Wealth Management reduced its AbbVie (ABBV) stake by 0.48% in Q2 2026, selling an estimated $39.6K and leaving 38,268 shares worth $9.63M. The position accounts for 4.27% of the portfolio, ranked #5.

Pacific Wealth Management first reported a position in ABBV in Q3 2022 and has held it in 16 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Pacific Wealth Management held 38,268 shares of AbbVie worth $9.63M as of Q2 2026.
  • Pacific Wealth Management sold 184 AbbVie shares in Q2 2026, an estimated $39.6K.
  • AbbVie made up 4.27% of Pacific Wealth Management's portfolio in Q2 2026, its #5 holding.
  • Pacific Wealth Management first reported a position in AbbVie in Q3 2022 and has held it in 16 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pacific Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.